Abstract
In 2003, Dr. Marjatta Leirisalo and Dr. Leena Paimela from Helsinki brought sera from rheumatoid arthritis patients to London to be investigated for antibodies to Proteus as well as against peptide sequences crossreacting with HLA-DR1/4 antigens.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Carty SM, Snowden M, Silman AJ. Should infection still be considered as the most likely triggering factor for rheumatoid arthritis ? J Rheumatol. 2003;30:425–9.
Nakai Y, Wakisaka A, Aizawa M, Itakura K, Nakai H, Ohashi A. HLA and rheumatoid arthritis in Japanese. Arthritis Rheum. 1981;24:722–5.
Rashid T, Leirisalo-Repo M, Tani Y, Hukuda S, Kobayashi S, Wilson C, et al. Antibacterial and antipeptide antibodies in Japanese and Finnish patients with rheumatoid arthritis. Clin Rheumatol. 2004;23:134–41.
Wallin J, Hillert J, Olerup O, Carlsson B, Strom H. Association of rheumatoid arthritis with a dominant DR1/Dw4, Dw14 sequence motif, but not with a T cell receptor β chain gene alleles or haplotypes. Arthritis Rheum. 1991;34:1416–24.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag London Limited
About this chapter
Cite this chapter
Ebringer, A. (2011). Immune Responses to Proteus in Rheumatoid Arthritis Patients from Finland and Japan. In: Rheumatoid Arthritis and Proteus. Springer, London. https://doi.org/10.1007/978-0-85729-950-5_15
Download citation
DOI: https://doi.org/10.1007/978-0-85729-950-5_15
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-949-9
Online ISBN: 978-0-85729-950-5
eBook Packages: MedicineMedicine (R0)